Dax Abraham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dax Abraham has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Alpa Gupta
Department of Conservative Dentistry and Endodontics, Manav Rachna Dental College, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, India
12 shared publications - Arundeep Singh
Department of Conservative Dentistry and Endodontics, Manav Rachna Dental College, Faridabad, Haryana, India
7 shared publications - Sucheta Jala
Department of Conservative Dentistry and Endodontics, Manav Rachna Dental College, Faridabad, Haryana, India
6 shared publications - Vivek Aggarwal
Department of Conservative Dentistry and Endodontics, Jamia Milia Islamia, Ghaffar Manzil Colony, Jamia Nagar, Okhla, New Delhi, India
6 shared publications - Anjana Goyal
Department of Biochemistry, Manav Rachna Dental College, School of Dental Sciences, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, India
4 shared publications - Namrata Mehta
Department of Conservative Dentistry and Endodontics, Manav Racha Dental College, Faridabad, India
4 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Caleo in European Endodontic Journal
- Vol. 11  (9) , 406-414
Effect of Calcium Hydroxide as an Intracanal Medicament with Aqueous- and Viscous-Based Vehicles in Patients with Pulpal Necrosis and Symptomatic Apical Periodontitis on Post-operative Pain and Periapical Healing Outcome
Objective: This study aimed to measure the effect of calcium hydroxide with propylene glycol and calcium hydroxide with normal saline as intracanal medicament in patients with pulpal necrosis and symptomatic apical periodontitis on postoperative pain and periapical healing outcome. Methods: For this investigation, 50 patients with symptomatic apical periodontitis and pulpal necrosis in permanent mandibular molar teeth were chosen. Depending on the kind of intracanal medication utilised during the procedure, the participants were divided into 2 groups of 25 patients each at random. Group 1: calcium hydroxide and propylene glycol and group 2: calcium hydroxide and normal saline. All patients with pre-operative pain scores between 60 and 144 mm were asked to record the pain on the Heft–Parker visual analogue scale (HP-VAS) from 6, 24, 48, 72, 96 hours and days 5,6,7.td. The healing of periapical lesions was determined at 0 months, 3 months, 6 months, 9 months and 12 months using the periapical index (PAI) score. Results: No statistically significant difference in postoperative pain scores was observed between the groups at baseline and during the 1st-4th days (P > .05). The propylene glycol group demonstrated significantly lower pain scores on the 5th, 6th and 7th days compared to the normal saline group (P < .05). No significant difference in periapical healing was observed at the 3-month and 6-month follow-ups (P > .05); however, statistically significant improvements were observed in the propylene glycol group at 9 months and 12 months (P < .05). Conclusion: Calcium hydroxide used with a viscous vehicle (propylene glycol) demonstrated a greater reduction in postoperative pain after day 4 and improved periapical healing at 9 and 12 months compared to an aqueous vehicle (saline). Although statistically significant differences were observed at specific time points, the clinical relevance of these findings should be interpreted with caution, and further studies are required to confirm these results.
- 7 September 2026
- Published by Caleo in European Endodontic Journal
- Vol. 11  (9) , 406-414
Open AccessEffect of Calcium Hydroxide as an Intracanal Medicament with Aqueous- and Viscous-Based Vehicles in Patients with Pulpal Necrosis and Symptomatic Apical Periodontitis on Post-operative Pain and Periapical Healing Outcome
Objective: This study aimed to measure the effect of calcium hydroxide with propylene glycol and calcium hydroxide with normal saline as intracanal medicament in patients with pulpal necrosis and symptomatic apical periodontitis on postoperative pain and periapical healing outcome. Methods: For this investigation, 50 patients with symptomatic apical periodontitis and pulpal necrosis in permanent mandibular molar teeth were chosen. Depending on the kind of intracanal medication utilised during the procedure, the participants were divided into 2 groups of 25 patients each at random. Group 1: calcium hydroxide and propylene glycol and group 2: calcium hydroxide and normal saline. All patients with pre-operative pain scores between 60 and 144 mm were asked to record the pain on the Heft–Parker visual analogue scale (HP-VAS) from 6, 24, 48, 72, 96 hours and days 5,6,7.td. The healing of periapical lesions was determined at 0 months, 3 months, 6 months, 9 months and 12 months using the periapical index (PAI) score. Results: No statistically significant difference in postoperative pain scores was observed between the groups at baseline and during the 1st-4th days (P > .05). The propylene glycol group demonstrated significantly lower pain scores on the 5th, 6th and 7th days compared to the normal saline group (P < .05). No significant difference in periapical healing was observed at the 3-month and 6-month follow-ups (P > .05); however, statistically significant improvements were observed in the propylene glycol group at 9 months and 12 months (P < .05). Conclusion: Calcium hydroxide used with a viscous vehicle (propylene glycol) demonstrated a greater reduction in postoperative pain after day 4 and improved periapical healing at 9 and 12 months compared to an aqueous vehicle (saline). Although statistically significant differences were observed at specific time points, the clinical relevance of these findings should be interpreted with caution, and further studies are required to confirm these results.
- Open Access
- 28 August 2026
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16  (5)
Oxidative stress burden in endodontic infection: Gingival crevicular fluid 8-isoprostane in hypertensive patients with symptomatic apical periodontitis cross sectional observational study
- 28 August 2026
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16  (5)
Open AccessOxidative stress burden in endodontic infection: Gingival crevicular fluid 8-isoprostane in hypertensive patients with symptomatic apical periodontitis cross sectional observational study
- Open Access
- 6 April 2026
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16  (3) , 101447
Spatiotemporal quantification of gingival crevicular fluid NLRP3 expression during non-surgical endodontic management of pulp necrosis with symptomatic apical periodontitis: A prospective case-control analysis
- 6 April 2026
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16  (3) , 101447
Open AccessSpatiotemporal quantification of gingival crevicular fluid NLRP3 expression during non-surgical endodontic management of pulp necrosis with symptomatic apical periodontitis: A prospective case-control analysis
- 17 March 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 169, 106637
Single-visit versus multiple-visit root canal therapy: Post-endodontic pain outcomes from an umbrella review
- 17 March 2026
- Published by Elsevier in Journal of Dentistry
- Vol. 169, 106637
Single-visit versus multiple-visit root canal therapy: Post-endodontic pain outcomes from an umbrella review
- Open Access
- 7 February 2026
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16  (2) , 101413
Association of NLRP3 (rs4612666) polymorphism in gingival crevicular fluid with symptomatic irreversible pulpitis and asymptomatic apical periodontitis
- 7 February 2026
- Published by Elsevier in Journal of Oral Biology and Craniofacial Research
- Vol. 16  (2) , 101413
Open AccessAssociation of NLRP3 (rs4612666) polymorphism in gingival crevicular fluid with symptomatic irreversible pulpitis and asymptomatic apical periodontitis
- Open Access
- 21 October 2025
- Published by Springer Nature in Discover Applied Sciences
- Vol. 7  (11)
Salivary matrix metalloproteinases in periodontitis and cardiovascular disease: a systematic review
- 21 October 2025
- Published by Springer Nature in Discover Applied Sciences
- Vol. 7  (11)
Open AccessSalivary matrix metalloproteinases in periodontitis and cardiovascular disease: a systematic review
- Open Access
- 1 September 2025
- Published by Wolters Kluwer Health in Journal of International Society of Preventive and Community Dentistry
- Vol. 15  (5) , 415-425
GCF NLRP3 as a Biomarker for Assessing Endodontic Treatment Outcomes in Symptomatic Irreversible Pulpitis: A Comparative Nonrandomized, Observational Cross-Sectional Study
A bstract: Aim: Biomarker-based evaluation of endodontic outcomes offers an objective alternative to traditional clinical assessments. The human nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing-3 (NLRP3) inflammasome is emerging as a potential indicator in inflammatory dental conditions. The aim was to correlate changes in pain levels with gingival crevicular fluid (GCF) levels of the NLRP3 inflammasome in patients with symptomatic irreversible pulpitis (SIP), before and after nonsurgical endodontic treatment. Materials and Methods: This nonrandomized matched comparative study included 15 SIP patients (45 teeth: involved, adjacent, and contralateral) and 15 healthy controls (15 teeth). GCF samples were analyzed via enzyme-linked immunosorbent assay. Pain was assessed using the Heft Parker visual analog scale (HP-VAS). Data were analyzed using linear mixed models, the Wilcoxon signed-rank test, and the Spearman correlation. Results: Baseline GCF-NLRP3 levels were significantly higher in SIP-affected teeth (4.33 ± 0.98 ng/mL) than in controls (1.34 ± 0.45 ng/mL; P < 0.001). A significant difference was observed between involved and contralateral teeth (mean difference = 2.96; 95% CI = 2.28–3.65). Post-treatment levels in both involved and adjacent teeth decreased ( P < 0.05). HP-VAS scores also showed a significant reduction (median difference: 69; P < 0.001). The reduction in the NLRP3 inflammasome activity was significantly correlated with pain reduction, with P value (r = 0.686; 95% CI = 0.22–0.91). Conclusion: GCF-NLRP3 levels can serve as a reliable biomarker for evaluating endodontic treatment outcomes in SIP, reflecting both local inflammation and patient-reported pain. Integrating GCF-NLRP3 monitoring may enhance the diagnostic accuracy and inform treatment planning. Future studies should assess longitudinal trends and therapeutic thresholds. GCF-NLRP3 could be a promising biomarker for assessing the outcome of endodontic treatment. This finding opens up new possibilities for improving the efficacy of endodontic procedures and, ultimately, patient care Clinical Trial Registration: The clinical study was registered under the clinical trial registry-India www.ctri.nic.in (CTRI/2023/07/055526) on July 24, 2023. The supporting document can be produced through requisition mail to the corresponding author.
- 1 September 2025
- Published by Wolters Kluwer Health in Journal of International Society of Preventive and Community Dentistry
- Vol. 15  (5) , 415-425
Open AccessGCF NLRP3 as a Biomarker for Assessing Endodontic Treatment Outcomes in Symptomatic Irreversible Pulpitis: A Comparative Nonrandomized, Observational Cross-Sectional Study
A bstract: Aim: Biomarker-based evaluation of endodontic outcomes offers an objective alternative to traditional clinical assessments. The human nucleotide-binding domain, leucine-rich repeat, and pyrin domain-containing-3 (NLRP3) inflammasome is emerging as a potential indicator in inflammatory dental conditions. The aim was to correlate changes in pain levels with gingival crevicular fluid (GCF) levels of the NLRP3 inflammasome in patients with symptomatic irreversible pulpitis (SIP), before and after nonsurgical endodontic treatment. Materials and Methods: This nonrandomized matched comparative study included 15 SIP patients (45 teeth: involved, adjacent, and contralateral) and 15 healthy controls (15 teeth). GCF samples were analyzed via enzyme-linked immunosorbent assay. Pain was assessed using the Heft Parker visual analog scale (HP-VAS). Data were analyzed using linear mixed models, the Wilcoxon signed-rank test, and the Spearman correlation. Results: Baseline GCF-NLRP3 levels were significantly higher in SIP-affected teeth (4.33 ± 0.98 ng/mL) than in controls (1.34 ± 0.45 ng/mL; P < 0.001). A significant difference was observed between involved and contralateral teeth (mean difference = 2.96; 95% CI = 2.28–3.65). Post-treatment levels in both involved and adjacent teeth decreased ( P < 0.05). HP-VAS scores also showed a significant reduction (median difference: 69; P < 0.001). The reduction in the NLRP3 inflammasome activity was significantly correlated with pain reduction, with P value (r = 0.686; 95% CI = 0.22–0.91). Conclusion: GCF-NLRP3 levels can serve as a reliable biomarker for evaluating endodontic treatment outcomes in SIP, reflecting both local inflammation and patient-reported pain. Integrating GCF-NLRP3 monitoring may enhance the diagnostic accuracy and inform treatment planning. Future studies should assess longitudinal trends and therapeutic thresholds. GCF-NLRP3 could be a promising biomarker for assessing the outcome of endodontic treatment. This finding opens up new possibilities for improving the efficacy of endodontic procedures and, ultimately, patient care Clinical Trial Registration: The clinical study was registered under the clinical trial registry-India www.ctri.nic.in (CTRI/2023/07/055526) on July 24, 2023. The supporting document can be produced through requisition mail to the corresponding author.
- Open Access
- 25 July 2025
- Published by Georg Thieme Verlag KG in European Journal of General Dentistry
- Vol. 15  (02) , 262-270
A Comparative Analysis of Effect of Statins in Cardiovascular Patients on Root Canal Calcification Using CBCT: A Retrospective Study
Root canal calcification (RCC) occurs as a diffuse phenomenon, making endodontic treatment challenging. Various factors like systemic diseases and medication induce the calcification process. It has been stated in studies that statin causes odontoblastic differentiation of human dental pulp stem cells, causing RCC. The objective of the study was to evaluate and compare RCC in healthy individuals and cardiovascular patients with and without statin therapy using cone-beam computed tomography (CBCT). This retrospective study comprises three groups in which group 1 consisted of healthy individuals, group 2 consisted of cardiovascular patients not taking statin medication, and group 3 consisted of cardiovascular patients taking statin medication. The study included healthy first or second mandibular molar. CBCT was utilized to detect the RCC in terms of volume measurement among all the groups. For inferential analysis, a one-way analysis of variance and post hoc Tukey's test will assess the significance of sample means against known values. The pairwise comparison revealed that there is no significant difference between group 1 and group 2, and comparatively, group 3 significantly has higher calcification (least volume) than groups 1 and 2 in both mandibular first and second molar. Systemic medications like statin possess an increased risk of RCC due to odontoblastic differentiation of human dental pulp stem cells. CBCT should be employed as a diagnostic tool for accurate diagnosis of RCC and correlating systemic oral illness and facilitating early diagnosis.
- 25 July 2025
- Published by Georg Thieme Verlag KG in European Journal of General Dentistry
- Vol. 15  (02) , 262-270
Open AccessA Comparative Analysis of Effect of Statins in Cardiovascular Patients on Root Canal Calcification Using CBCT: A Retrospective Study
Root canal calcification (RCC) occurs as a diffuse phenomenon, making endodontic treatment challenging. Various factors like systemic diseases and medication induce the calcification process. It has been stated in studies that statin causes odontoblastic differentiation of human dental pulp stem cells, causing RCC. The objective of the study was to evaluate and compare RCC in healthy individuals and cardiovascular patients with and without statin therapy using cone-beam computed tomography (CBCT). This retrospective study comprises three groups in which group 1 consisted of healthy individuals, group 2 consisted of cardiovascular patients not taking statin medication, and group 3 consisted of cardiovascular patients taking statin medication. The study included healthy first or second mandibular molar. CBCT was utilized to detect the RCC in terms of volume measurement among all the groups. For inferential analysis, a one-way analysis of variance and post hoc Tukey's test will assess the significance of sample means against known values. The pairwise comparison revealed that there is no significant difference between group 1 and group 2, and comparatively, group 3 significantly has higher calcification (least volume) than groups 1 and 2 in both mandibular first and second molar. Systemic medications like statin possess an increased risk of RCC due to odontoblastic differentiation of human dental pulp stem cells. CBCT should be employed as a diagnostic tool for accurate diagnosis of RCC and correlating systemic oral illness and facilitating early diagnosis.
- 2 July 2025
- Published by Elsevier in Journal of Dentistry
- Vol. 161, 105943
Association between cardiovascular diseases and apical periodontitis: An umbrella review with stratification of evidence and sensitivity analysis
- 2 July 2025
- Published by Elsevier in Journal of Dentistry
- Vol. 161, 105943
Association between cardiovascular diseases and apical periodontitis: An umbrella review with stratification of evidence and sensitivity analysis
- Open Access
- 30 June 2025
- Published by Biomedical Informatics in Bioinformation
- Vol. 21  (06) , 1680-1682
Role of salivary MMP-9 in OSCC detection and diagnosis: A comprehensive clinical assessment
An Enzyme-Linked Immunosorbent Assay (ELISA) to measure the salivary Matrix metalloproteinase-9 (MMP-9) levels among squamous cell carcinoma patients was used. Thirty of the sixty participants in the research had a verified diagnosis of oral SCC, whereas the remaining twenty were healthy controls. Salivary MMP-9 levels were extracted by centrifugation and measured using ELISA. The results were compared between oral SCC patients and controls. Participants with oral squamous cell carcinoma had considerably greater mean salivary MMP-9 levels than healthy subjects (p<0.05). Thus, individuals with oral squamous cell carcinoma have average salivary MMP-9 levels, and those with poorly differentiated oral squamous cell carcinoma have even higher levels.
- 30 June 2025
- Published by Biomedical Informatics in Bioinformation
- Vol. 21  (06) , 1680-1682
Open AccessRole of salivary MMP-9 in OSCC detection and diagnosis: A comprehensive clinical assessment
An Enzyme-Linked Immunosorbent Assay (ELISA) to measure the salivary Matrix metalloproteinase-9 (MMP-9) levels among squamous cell carcinoma patients was used. Thirty of the sixty participants in the research had a verified diagnosis of oral SCC, whereas the remaining twenty were healthy controls. Salivary MMP-9 levels were extracted by centrifugation and measured using ELISA. The results were compared between oral SCC patients and controls. Participants with oral squamous cell carcinoma had considerably greater mean salivary MMP-9 levels than healthy subjects (p<0.05). Thus, individuals with oral squamous cell carcinoma have average salivary MMP-9 levels, and those with poorly differentiated oral squamous cell carcinoma have even higher levels.